Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001872873-26-000002

PRESIDENT AND CEO gave up 1,339 shares (to pay taxes)

  • PRESIDENT AND CEO acquired 4,514 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jiang Wenbin PRESIDENT AND CEO 2026-02-18 Option exercise +4,514 5,361,166 D
Jiang Wenbin PRESIDENT AND CEO 2026-02-18 Shares withheld for taxes −1,339 $4.20 $5,624 5,359,827 D
Derivatives
Jiang Wenbin PRESIDENT AND CEO 2026-02-18 Option exercise · Restricted Stock Units −4,514 0 D
Loading xslF345X05/form4-02202026_100254.xml…